NJ ACTS receives 7-year grant renewal of $39.7M from NIH

May 15, 2024

Dan Notterman, Professor of the Practice in Molecular Biology and Senior Advisor to the Provost for Biomedical Affairs, will continue to lead Princeton’s partnership in the New Jersey Alliance for Clinical and Translational Science (NJ ACTS) with Rutgers, NJIT and RWJBarnabas Health to advance moving research discoveries into clinical practice and improve health care in New Jersey.

Over the last 5 years, Princeton has benefited from opportunities, resources, expertise, and funding available through the Alliance. Seventeen faculty investigators across departments received NJ ACTS collaborative pilot research awards, while seven postdocs and five doctoral students received translational science fellowship awards.

Read the full story...